Skip to main content

Advertisement

Log in

Increased H2O2 level in exhaled breath condensate in primary breast cancer patients

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

This study was designed to assess exhaled hydrogen peroxide (H2O2), blood serum antioxidant capacity, and tumor necrosis factor-α (TNFα) in primary breast cancer (PBC).

Methods

The study included 34 consecutive, non-smoking PBC patients (aged 62.5 ± 13.5 at surgery) prior to the treatments, qualified for modified radical mastectomy and not undergoing any adjuvant systemic therapy, and 33 healthy controls. The post surgery pathological assessment included tissue expression of estrogen (ER) and progesterone (PR) receptors, and epidermal growth factor receptor type 2 (HER-2/neu). Exhaled H2O2 was determined fluorometrically in the exhaled breath condensate (EBC). Blood serum antioxidant capacity and TNFα levels were assessed with ferric reducing ability of plasma (FRAP) and ELISA immunoassay, respectively.

Results

In PBC patients, 10 ER, 11 PR, and 9 HER-2/neu positive tumors were identified and HER-2/neu score was 2+ in 20% of all tumors. Median (Me) H2O2 was increased up to 0.44 μM (interquartile range IR: 0.20–1.25 μM) compared with healthy control of 0.36 μM (IR: 0.12–0.48 μM; p < 0.05). The H2O2 concentration in EBC was significantly correlated (τ = 0.27; p = 0.03) and increased in cases with nodal metastases (n = 12; p = 0.04). Serum TNFα was increased up to 51.7 ± 21.0 pg/ml compared with controls 17.2 ± 3.65 pg/ml (p < 0.05). FRAP was increased to 1.41 ± 0.37 mM Fe2+ compared with control 1.19 ± 0.17 mM Fe2+; (p = 0.006).

Conclusions

This is the first study to demonstrate increased H2O2 in exhaled breath condensate in patients with localized breast malignancy and its relation with clinical severity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

EBC:

Exhaled breath condensate

FRAP:

Ferric reducing ability of plasma

HER:

-2/neu human epidermal growth factor cell surface receptor-2

IHC:

Immunohistochemistry

PBC:

Primary breast cancer

ROS:

Reactive oxygen species

References

  • Adzic M, Niciforovic A, Vucic V, Neskovic-Konstantinovic Z, Spasic SD, Jones DR, Radojcic MB, Spasic MB (2006) Systemic NF-kappaB activation in blood cells of breast cancer patients. Redox Rep 11:39–44

    Article  CAS  PubMed  Google Scholar 

  • Bae I, Fan S, Meng Q, Rih JK, Kim HJ, Kang HJ, Xu J, Goldberg I, Jaiswal AK, Rosen EM (2004) BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res 64:7893–7909

    Article  CAS  PubMed  Google Scholar 

  • Balogh N, Gaal T, Ribiczeyne PS, Petri A (2001) Biochemical and antioxidant changes in plasma and erythrocytes of pentathlon horses before and after exercise. Vet Clin Pathol 30:214–218

    Article  PubMed  Google Scholar 

  • Benzie IFF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of ‘antioxidant power’: the FRAP assay. Anal Biochem 239:70–76

    Article  CAS  PubMed  Google Scholar 

  • Carney WP, Leitzel K, Ali S, Neumann R, Lipton A (2007) HER-2/neu diagnostics in breast cancer. Breast Cancer Res 9:207

    Article  PubMed  Google Scholar 

  • Dasari A, Bartholomew JN, Volonte D, Galbiati F (2006) Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements. Cancer Res 22:10805–10814

    Google Scholar 

  • De Benedetto F, Aceto A, Dragani B, Spacone A, Formisano S, Pela R, Donner CF, Sanguinetti CM (2005) Long-term oral N-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD. Pulm Pharmacol Ther 18:41–47

    Article  PubMed  Google Scholar 

  • de Cavanagh EM, Honegger AE, Hofer E, Bordenave RH, Bullorsky EO, Chasseing NA, Fraga C (2002) Higher oxidation and lower antioxidant levels in peripheral blood plasma and bone marrow plasma from advanced cancer patients. Cancer 94:3247–3251

    Article  PubMed  Google Scholar 

  • Degraft-Johnson J, Kolodziejczyk K, Krol M, Nowak P, Krol B, Nowak D (2007) Ferric-reducing ability power of selected plant polyphenols and their metabolites: implications for clinical studies on the antioxidant effects of fruits and vegetable consumption. Basic Clin Pharmacol Toxicol 100:345–352

    Article  CAS  PubMed  Google Scholar 

  • Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, van’t Veer LJ, Perou CM (2006) Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355:560–569

    Article  CAS  PubMed  Google Scholar 

  • Garcia-Tunon I, Ricote M, Ruiz A, Fraile B, Paniagua R, Royuela M (2006) Role of tumor necrosis factor-alpha and its receptors in human benign breast lesions and tumors (in situ and infiltrative). Cancer Sci 97(10):1044–1049

    Article  CAS  PubMed  Google Scholar 

  • Gaudet MM, Egan KM, Lissowska J, Newcomb PA, Brinton LA, Titus-Ernstoff L, Yeager M, Chanock S, Welch R, Peplonska B, Trentham-Dietz A, Garcia-Closas M (2007) Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet 121:483–490

    Article  CAS  PubMed  Google Scholar 

  • Gerristen WB, Asin J, Zanen P, van der Bosch JM, Haas FJ (2005) Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients. Respir Med 99:84–90

    Article  Google Scholar 

  • Hietanen E, Bartsch H, Bereziat JC, Camus AM, McClinton S, Eremin O, Davidson L, Boyle P (1994) Diet and oxidative stress in breast, colon and prostate cancer patients: a case–control study. Eur J Clin Nutr 48:575–586

    CAS  PubMed  Google Scholar 

  • Kasapović J, Pejić S, Todorović A, Stojiljković V, Pajović SB (2008) Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages. Cell Biochem Funct 26:723–730

    Article  PubMed  Google Scholar 

  • Korkaya H, Paulson A, Iovino F, Wicha MS (2008) HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene 27:6120–6130

    Article  CAS  PubMed  Google Scholar 

  • Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S (2003) Oxidative stress in expired breath condensate of patients with COPD. Chest 124:1373–1380

    Article  CAS  PubMed  Google Scholar 

  • Koutsokera A, Loukides S, Gourgoulianis KI, Kostikas K (2008) Biomarkers in the exhaled breath condensate of healthy adults: mapping the path towards reference values. Curr Med Chem 15:620–630

    Article  CAS  PubMed  Google Scholar 

  • Kuo PL, Hsu YL, Lin TC, Tzeng WS, Chen YY, Lin CC (2006) Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-kappaB signaling pathway. Cancer Lett 259:82–98

    Google Scholar 

  • Loukides S, Bouros D, Papatheodorou G, Panagou P, Siafakas NM (2002) The relationships among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. Chest 121:338–346

    Article  CAS  PubMed  Google Scholar 

  • Luo Y, Zhou H, Krueger J, Kaplan C, Lee SH, Dolman C, Markowitz D, Wu W, Liu C, Reisfeld RA, Xiang R (2006) Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest 116:2132–2141

    Article  CAS  PubMed  Google Scholar 

  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force (2005) Standardisation of spirometry. Eur Respir J 26:319–338

    Article  CAS  PubMed  Google Scholar 

  • Moore A (2007) Breast-cancer therapy—looking back to the future. N Engl J Med 357:1547–1549

    Article  CAS  PubMed  Google Scholar 

  • Nass SJ, Davidson NE (1999) The biology of breast cancer. Hematol Oncol Clin North Am 13:311–332

    Article  CAS  PubMed  Google Scholar 

  • Nowak D, Kasielski M, Antczak A, Pietras T, Bialasiewicz P (1999) Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 93:389–396

    Article  CAS  PubMed  Google Scholar 

  • Phillips M, Cataneo RN, Ditkoff BA, Fisher P, Greenberg J, Gunawardena R, Kwon CS, Rahbari-Oskoui F, Wong C (2003) Volatile markers of breast cancer in the breath. Breast J 9:184–191

    Article  PubMed  Google Scholar 

  • Phillips M, Cataneo RN, Ditkoff BA, Fisher P, Greenberg J, Gunawardena R, Kwon CS, Tietje O, Wong C (2006) Prediction of breast cancer using volatile biomarkers in the breath. Breast Cancer Res Treat 99:19–21

    Article  CAS  PubMed  Google Scholar 

  • Rysz J, Kasielski M, Apanasiewicz J, Król M, Woźnicki A, Luciak M, Nowak D (2004) Increased hydrogen peroxide in the exhaled breath of uraemic patients unaffected by haemodialysis. Nephrol Dial Transplant 19:158–163

    Article  CAS  PubMed  Google Scholar 

  • Rysz J, Stolarek RA, Pedzik A, Fijalkowska J, Luczynska M, Sarniak A, Kasielski M, Makowka A, Nowicki M, Nowak D (2007) Increased exhaled H2O2 and impaired lung function in patients undergoing bioincompatible hemodialysis. Int J Artif Organs 30:879–888

    CAS  PubMed  Google Scholar 

  • Schmielau J, Finn OJ (2001) Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-Cell function in advanced cancer patients. Cancer Res 61:4756–4760

    CAS  PubMed  Google Scholar 

  • Stolarek R, Szkudlarek U, Luczynska M, Kasielski M, Ciesla W, Lewinski A, Nowak D (2008) Decreased H2O2 in exhaled breath condensate during pregnancy-feasible effect of 17beta-estradiol. Respir Physiol Neurobiol 162:152–159

    Article  CAS  PubMed  Google Scholar 

  • Szkudlarek U, Maria L, Kasielski M, Kaucka S, Nowak D (2003) Exhaled hydrogen peroxide correlates with the release of reactive oxygen species by blood phagocytes in healthy subjects. Respir Med 97:718–725

    Article  CAS  PubMed  Google Scholar 

  • Xu J, Zhou JY, Wu GS (2006) Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapy. Cancer Res 66:10092–10099

    Article  CAS  PubMed  Google Scholar 

  • Yau C, Benz CC (2008) Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers. Breast Cancer Res 10:R61

    Article  PubMed  Google Scholar 

  • Zhang J, Warren MA, Shoemaker SF, Ip MM (2007) NFkappaB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFkappaB2/p52 and RelB. Endocrinology 148:268–278

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest statement

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dariusz Nowak.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stolarek, R.A., Potargowicz, E., Sęklewska, E. et al. Increased H2O2 level in exhaled breath condensate in primary breast cancer patients. J Cancer Res Clin Oncol 136, 923–930 (2010). https://doi.org/10.1007/s00432-009-0734-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-009-0734-x

Keywords

Navigation